National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

ramelteon
A synthetic melatonin analogue with hypnotic and circadian rhythm-modulating activities. Ramelteon binds to and activates melatonin receptors 1 and 2 in the suprachiasmatic nucleus (SCN) of the brain, thereby promoting the onset of sleep. Unlike the nonbenzodiazepine sedative hypnotics zolpidem and zaleplon, this agent does not activate GABA receptors and, so, produces no GABA receptor-mediated anxiolytic, myorelaxant, and amnesic effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Rozerem



Previous:racemic XK469, RadiaPlex Rx Gel, Raf kinase inhibitor XL281, raloxifene, raltitrexed
Next:ramucirumab, ranibizumab, ranimustine, ranpirnase, Rapamune

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov